2011
DOI: 10.1007/s00018-011-0751-1
|View full text |Cite|
|
Sign up to set email alerts
|

BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain

Abstract: Bone Morphogenetic Protein 9 (BMP9) has been recently found to be the physiological ligand for the activin receptor-like kinase 1 (ALK1), and to be a major circulating vascular quiescence factor. Moreover, a soluble chimeric ALK1 protein (ALK1-Fc) has recently been developed and showed powerful anti-tumor growth and anti-angiogenic effects. However, not much is known concerning BMP9. This prompted us to investigate the human endogenous sources of this cytokine and to further characterize its circulating form(s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

15
186
2
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 157 publications
(217 citation statements)
references
References 41 publications
(67 reference statements)
15
186
2
1
Order By: Relevance
“…In addition to their roles in lymphatic development, cardiac development, and postnatal retinal vascularization (8,30,31), we now show that BMP9 and BMP10 are also important for the closure of the DA. This result is in accordance with the high circulating levels of BMP9 and BMP10 in mice around birth (7,8). It will be interesting in the future to measure circulating levels of BMP9 and BMP10 in term and preterm infants to test whether there is also an increase in these two factors around birth, and whether we can correlate the circulating levels of these BMPs with the risk of PDA.…”
Section: Discussionsupporting
confidence: 80%
See 1 more Smart Citation
“…In addition to their roles in lymphatic development, cardiac development, and postnatal retinal vascularization (8,30,31), we now show that BMP9 and BMP10 are also important for the closure of the DA. This result is in accordance with the high circulating levels of BMP9 and BMP10 in mice around birth (7,8). It will be interesting in the future to measure circulating levels of BMP9 and BMP10 in term and preterm infants to test whether there is also an increase in these two factors around birth, and whether we can correlate the circulating levels of these BMPs with the risk of PDA.…”
Section: Discussionsupporting
confidence: 80%
“…In 2007, it was demonstrated that BMP9 and BMP10 bind with high affinity to the endothelial-specific receptor activin receptor-like kinase 1 (ALK1), a type 1 receptor of the TGFβ family (6) whose mutations are involved in vascular diseases (5). Both BMP9 and BMP10 are present in blood, and their circulating levels are particularly elevated in mice around birth (7,8), suggesting that they could play a role in pre-and postnatal development. In the present work, we addressed whether BMP9 and BMP10 could be involved in DA closure.…”
mentioning
confidence: 99%
“…To better understand such differences among members of the TGF-β family, we examine the structure of pro-BMP9 and compare it to the previously described, cross-armed conformation of pro-TGF-β1 (10). Although a member of the BMP subfamily and possessing chondrogenic and osteogenic activity, BMP9 is expressed in liver and is required for properly organized blood and lymphatic vascular development (11,12). Mutations in the prodomain of BMP9, in its receptor Alk1, and in its coreceptor endoglin cause phenotypically overlapping hereditary hemorrhagic telangiectasias (13)(14)(15).…”
mentioning
confidence: 99%
“…We anticipate occurrence of these and also interactions between BMP9 and the GH-STAT5 axis in pulmonary vascular cells (see comments on BMP9 in previous section and refs. [79][80][81][82][83][84].…”
Section: Synthesis Of the Literature On Sex Bias Mediated By The Neurmentioning
confidence: 99%